Limited activity: This researcher has not published recently (last publication: 2009). Profile data may be outdated.
Match tier Listed
Presence Current · Arkansas
Last published 2009
Sources OpenAlex · ORCID
Refreshed 2026-10-04

B Barlogie

Role not yet determined Is this you? Add your title

UAMS
1 pubs

Research Areas

Biomedical Subjects

  • Humans
  • Multiple Myeloma
  • Middle Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Prognosis
  • Melphalan
  • Dexamethasone
  • DNA
  • RNA
  • Female
  • Male
  • Hematopoietic Stem Cell Transplantation
  • Neoplasms, Second Primary
  • Cell Cycle
  • Doxorubicin

OverviewAI-generated summary

B Barlogie's research has focused on multiple myeloma, a cancer of plasma cells. Their work has investigated the biological insights and therapeutic advances in this disease, including the use of various chemotherapy regimens and novel agents. Several publications address the prognostic implications of tumor cell DNA and RNA content in multiple myeloma, suggesting a link between genetic material and patient outcomes. Additionally, Barlogie has contributed to meta-analyses examining the side effects of therapies, such as the incidence of second primary malignancies associated with lenalidomide treatment for newly diagnosed myeloma. Their research also touches upon the efficacy of specific drugs like fludarabine in related hematological conditions such as chronic lymphocytic leukemia and Waldenström's macroglobulinemia.

Metrics

  • Publications: 1

Selected Publications

  • Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma (2024)
    American Journal of Hematology 3 citations DOI OpenAlex
  • Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data (2014)
    The Lancet Oncology 284 citations DOI OpenAlex
  • Five Gene Probes Carry Most Of The Discriminatory Power Of The 70-Gene Risk Model In Multiple Myeloma (2013)
    Blood 1 citation DOI OpenAlex
  • The Antimalarial Agent Artesunate Exerts Its Antimyeloma Activity By Affecting The Mitochondria and The Reactive Oxygen Status Of The Myeloma Cells and Its Efficacy Depends On Intracellular Bivalent Iron Levels (2013)
    Blood 2 citations DOI OpenAlex
  • IMWG consensus on maintenance therapy in multiple myeloma (2012)
    Blood 195 citations DOI OpenAlex
  • Molecular Pathogenesis of MGUS and Multiple Myeloma (2009)
    Clinical Lymphoma & Myeloma DOI OpenAlex
  • Developmental therapeutics for multiple myeloma—A road map for the future (2001)
    Seminars in Hematology 2 citations DOI OpenAlex
  • Thalidomide in the management of multiple myeloma (2001)
    Seminars in Oncology 52 citations DOI OpenAlex
  • Hematopoietic Stem Cell Autografts in Support of Myeloablative Therapy for Multiple Myeloma* (1994)
    Journal of Hematotherapy 3 citations DOI OpenAlex
  • Multiple myeloma and chronic lymphocytic leukemia: Parallels and contrasts (1992)
    The American Journal of Medicine 25 citations DOI OpenAlex
  • High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma (1990)
    Blood 77 citations DOI OpenAlex

View all publications on OpenAlex →

Collaborators

Researchers in the database who share publications

Bart Barlogie University of Arkansas for Medical Sciences 9 shared publications Guido J. K. Tricot University of Arkansas for Medical Sciences 2 shared publications Fenghuang Zhan University of Arkansas for Medical Sciences 1 shared publication Sharmilan Thanendrarajan University of Arkansas for Medical Sciences 1 shared publication John D. Shaughnessy University of Arkansas for Medical Sciences 1 shared publication Samer Al Hadidi University of Arkansas for Medical Sciences 1 shared publication Carolina Schinke University of Arkansas for Medical Sciences 1 shared publication Clyde Bailey University of Arkansas for Medical Sciences 1 shared publication

Similar Researchers

Based on overlapping research topics

Naveen Yarlagadda University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Cancer Treatment and Pharmacology Meta-analysis and systematic reviews
Good match 4 shared topics
Abdul Rafae University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Cancer Treatment and Pharmacology Meta-analysis and systematic reviews
Good match 4 shared topics
Jenat Rahman University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Disease Mechanisms Research
Good match 4 shared topics
Edward T.H. Yeh University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Disease Mechanisms Research
Good match 4 shared topics
Sharon Amole University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Meta-analysis and systematic reviews Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Hayley M. Sabol University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies
Good match 4 shared topics